Cargando…

Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania

BACKGROUND: Diarrheagenic Escherichia coli (E. coli) is an important cause of diarrheal diseases in both developing countries and industrialized countries. An outbreak of hemolytic uremic syndrome (HUS) in young children from southern Romania was reported in early 2016 and was attributed to Shiga to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falup-Pecurariu, Oana, Lixandru, Raluca Ileana, Cojocaru, Emanuela, Csutak, Katalin, Monescu, Vlad, Muhsen, Khitam, Falup-Pecurariu, Cristian, Cohen, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761720/ https://www.ncbi.nlm.nih.gov/pubmed/31572497 http://dx.doi.org/10.1186/s13099-019-0327-4

Ejemplares similares

Personalized Assessment of Insomnia and Sleep Quality in Patients with Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2022)

Overview of the pediatric healthcare system in Romania
por: Pop, Tudor Lucian, et al.
Publicado: (2020)

Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children — are we there yet? A systematic review of randomised controlled trials
por: Ben-Shimol, Shalom, et al.
Publicado: (2014)

Editorial: Movement Disorders and Sleep – Underlying Mechanisms, Clinical Aspects and Treatment
por: Falup-Pecurariu, Cristian, et al.
Publicado: (2019)

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Dry eye in Parkinson's disease: a narrative review
por: Ungureanu, Larisa, et al.
Publicado: (2023)

Nocturia and Sleep in Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
por: Mayer, Chad L., et al.
Publicado: (2012)

Management of Orthostatic Hypotension in Parkinson’s Disease
por: Fanciulli, Alessandra, et al.
Publicado: (2020)

The Dashboard Vitals of Parkinson’s: Not to Be Missed Yet an Unmet Need
por: Chaudhuri, Kallol Ray, et al.
Publicado: (2022)

Restless Legs Syndrome in Parkinson’s Disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
por: Chang, Hye Jin, et al.
Publicado: (2014)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2020)

Early Outcome of Multisystem Inflammatory Syndrome in Neonates Diagnosed following Prenatal Maternal COVID-19 Infection: A Three-Case Series
por: Terciu, Maria, et al.
Publicado: (2023)

Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?
por: Bielaszewska, Martina, et al.
Publicado: (2007)

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Buelli, Simona, et al.
Publicado: (2019)

New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome
por: Petruzziello-Pellegrini, Tania N, et al.
Publicado: (2013)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease
por: Tall, P., et al.
Publicado: (2023)

E-learning preferences of European junior neurologists—an EAYNT survey
por: Sztriha, Laszlo K., et al.
Publicado: (2012)

Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities
por: McCoy, Nicole, et al.
Publicado: (2014)

Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina
por: Torti, Jeronimo F, et al.
Publicado: (2021)

Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome
por: Liu, Yang, et al.
Publicado: (2022)

Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands
por: Kassianos, George, et al.
Publicado: (2016)

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
por: Álvarez, Romina S., et al.
Publicado: (2021)

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
por: Boura, Iro, et al.
Publicado: (2023)

Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines
por: Usonis, Vytautas, et al.
Publicado: (2016)

Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000
por: Tozzi, Alberto E., et al.
Publicado: (2003)

Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome
por: Detzner, Johanna, et al.
Publicado: (2020)

Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome
por: Wijnsma, Kioa L., et al.
Publicado: (2020)

Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden
por: Hua, Ying, et al.
Publicado: (2021)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management
por: Travert, Benoit, et al.
Publicado: (2021)

Heparin-induced thrombocytopenia following Shiga-toxin-associated hemolytic uremic syndrome: a case report
por: Rigamonti, Elia, et al.
Publicado: (2022)

Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic–uremic syndrome: a pilot study
por: Neu, Charles, et al.
Publicado: (2023)

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023)

Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome
por: Chokoshvili, Otar, et al.
Publicado: (2014)

First Shiga Toxin-Producing Escherichia coli Isolate from a Patient with Hemolytic Uremic Syndrome, Brazil
por: Guth, Beatriz Ernestina C., et al.
Publicado: (2002)

Activation of the Nlrp3 Inflammasome Contributes to Shiga Toxin-Induced Hemolytic Uremic Syndrome in a Mouse Model
por: Song, Liqiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_djr94i7mqd0qli9b8rt0u5ogfr